Inside Health The Revolution in Cystic Fibrosis Care That is Changing Lives
Sep 2, 2025
Join Professor Sian Taylor-Philips, a Population Health expert and co-leader of the groundbreaking EDITH trial, as she discusses the incredible advancements in cystic fibrosis care. Discover how new therapies have transformed life expectancy for patients like Annabelle, who once faced limited futures. The conversation also dives into how artificial intelligence is set to revolutionize breast cancer detection, enhancing diagnosis accuracy and shaping healthcare policies for a better tomorrow.
AI Snips
Chapters
Transcript
Episode notes
Early Diagnosis And Childhood Treatment
- Annabelle was diagnosed at 12 months after persistent illness and a positive sweat chloride test.
- She describes intensive childhood therapies and hospital stays taught to her parents for long-term care.
From Childhood Fears To Unexpected Adulthood
- Annabelle once found in an old National Geographic that life expectancy was 18 and remembers telling her mother she didn't want to die at 18.
- She now has a daughter and describes adjusting to unexpected adult responsibilities after improved health.
How Modulators Target The Disease
- Cafetrio (a modulator) targets misfolded CF proteins to improve their function rather than changing DNA.
- This tackles the root cellular cause of cystic fibrosis rather than only treating infections and symptoms.